Cortisol and its relation to insulin resistance before and after weight loss in obese children

Thomas Reinehr1, Werner Andler

  • 1Vestische Kinder- und Jugendklinik, University of Witten-Herdecke, Datteln, Germany. T.Reinehr@kinderklinik-datteln.de

Hormone Research
|July 17, 2004
PubMed

Insights

Cortisol levels are higher in obese children with insulin resistance. Weight loss in these children significantly reduced both cortisol and insulin resistance, suggesting a link between the two.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Hormone Research

Background:

  • Insulin resistance is observed in obesity and Cushing's syndrome, hinting at cortisol's role.
  • Cortisol's potential involvement in insulin resistance among obese individuals warrants investigation.

Purpose of the Study:

  • To investigate the association between serum cortisol levels and insulin resistance in obese children.
  • To determine the impact of weight reduction on cortisol levels and insulin resistance in this population.

Main Methods:

  • Serum cortisol was measured in insulin-resistant obese children, non-insulin-resistant obese children, and healthy normal-weight children.
  • Multivariate linear regression analyzed factors influencing insulin resistance (HOMA), including BMI, age, gender, pubertal stage, and cortisol.
  • Cortisol and insulin resistance changes were tracked over one year in obese children with and without significant weight loss.

Main Results:

  • Obese children with insulin resistance exhibited significantly higher serum cortisol levels compared to normal-weight and non-insulin-resistant obese children.
  • Multivariate analysis confirmed that weight status (BMI), age, and cortisol significantly influenced insulin resistance.
  • Weight reduction in obese children led to significant decreases in both cortisol and insulin resistance.

Conclusions:

  • Elevated cortisol levels are associated with insulin resistance in obese children.
  • Weight reduction is an effective strategy for decreasing both cortisol levels and insulin resistance in this group.
  • These findings support a significant link between cortisol and insulin resistance within the context of childhood obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...